相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Defining the role of a FYVE domain in the localization and activity of a cAMP phosphodiesterase implicated in osmoregulation in Trypanosoma cruzi
Alejandra C. Schoijet et al.
MOLECULAR MICROBIOLOGY (2011)
Specific chemotherapy of Chagas disease: Relevance, current limitations and new approaches
Julio A. Urbina
ACTA TROPICA (2010)
Chagas disease in Spain, the United States and other non-endemic countries
Joaquim Gascon et al.
ACTA TROPICA (2010)
Chemical Validation of Phosphodiesterase C as a Chemotherapeutic Target in Trypanosoma cruzi, the Etiological Agent of Chagas' Disease
Sharon King-Keller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Identification of potent and reversible cruzipain inhibitors for the treatment of Chagas disease
Christian Beaulieu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
In vitro and in vivo experimental models for drug screening and development for Chagas disease
Alvaro Jose Romanha et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2010)
In Vitro and In Vivo High-Throughput Assays for the Testing of Anti-Trypanosoma cruzi Compounds
Adriana M. C. Canavaci et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Chemistry and Biology of Galactofuranose-Containing Polysaccharides
Michele R. Richards et al.
CHEMBIOCHEM (2009)
Changes in Trypanosoma cruzi-Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy
Susana A. Laucella et al.
CLINICAL INFECTIOUS DISEASES (2009)
Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities
Rodolfo Viotti et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2009)
Identification of Three Classes of Heteroaromatic Compounds with Activity against Intracellular Trypanosoma cruzi by Chemical Library Screening
Esther Bettiol et al.
PLOS NEGLECTED TROPICAL DISEASES (2009)
The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
Jacques Yves Gauthier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
A Trypanosoma cruzi Phosphatidylinositol 3-Kinase (TcVps34) Is Involved in Osmoregulation and Receptor-mediated Endocytosis
Alejandra C. Schoijet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
Juan M. Bustamante et al.
NATURE MEDICINE (2008)
Targeted gene deletion of Leishmania major UDP-galactopyranose mutase leads to attenuated virulence
Barbara Kleczka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Risedronate in the treatment of murine Chagas' disease
B Bouzahzah et al.
PARASITOLOGY RESEARCH (2005)
Antiparasitic activity of risedronate in a murine model of acute Chagas' disease
LR Garzoni et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase
SH Szajnman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei -: In vitro RNA interference and in vivo inhibition studies
A Montalvetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A critical review on Chagas disease chemotherapy
JR Coura et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2002)
Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase
A Montalvetti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Bisphosphonates derived from fatty acids are potent growth inhibitors of Trypanosoma cruzi
SH Szajnman et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2001)
分享论文
